Published in Nucleic Acids Res on September 05, 2013
Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications. Hum Gene Ther Methods (2015) 0.82
Control of human papillomavirus gene expression by alternative splicing. Virus Res (2016) 0.78
RNA Binding Proteins that Control Human Papillomavirus Gene Expression. Biomolecules (2015) 0.78
Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing. J Biol Chem (2015) 0.77
Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer. J Transl Med (2015) 0.76
Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation. Viruses (2017) 0.75
Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs. Int J Mol Sci (2017) 0.75
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem (2003) 21.11
Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet (2002) 16.29
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Classification of papillomaviruses. Virology (2004) 14.16
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
Cancer burden in the year 2000. The global picture. Eur J Cancer (2001) 10.47
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol (2009) 7.11
Cre recombinase: the universal reagent for genome tailoring. Genesis (2000) 6.29
Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol (1993) 5.24
Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet (2002) 4.97
The papillomavirus life cycle. J Clin Virol (2005) 3.41
Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n. Mol Cell Biol (1993) 2.84
SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J Cell Biol (1998) 2.69
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
Site-directed, Ligase-Independent Mutagenesis (SLIM): a single-tube methodology approaching 100% efficiency in 4 h. Nucleic Acids Res (2004) 2.54
Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Nat Methods (2004) 2.35
Functional diversity of the hnRNPs: past, present and perspectives. Biochem J (2010) 2.29
Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics (1998) 2.17
Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes. EMBO J (2007) 2.07
Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev (2009) 1.97
Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96
Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol Cell Biol (2001) 1.92
mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. Mol Cell (2012) 1.86
A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. Cancer Res (2002) 1.81
Systematic discovery of structural elements governing stability of mammalian messenger RNAs. Nature (2012) 1.80
Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol Cell Biol (2006) 1.77
A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J Biol Chem (2001) 1.77
The natural history of human papillomavirus infections of the mucosal epithelia. APMIS (2010) 1.61
Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res (2011) 1.59
Nuclear import and export functions in the different isoforms of the AUF1/heterogeneous nuclear ribonucleoprotein protein family. J Biol Chem (2003) 1.54
Cloning and expression of cDNA for a luciferase from the marine copepod Metridia longa. A novel secreted bioluminescent reporter enzyme. J Biol Chem (2003) 1.42
RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J Virol (2001) 1.41
Cooperative-binding and splicing-repressive properties of hnRNP A1. Mol Cell Biol (2009) 1.37
Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5' splice site selection in the hnRNP A1 mRNA precursor. J Biol Chem (2002) 1.36
Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant. Mol Cell Biol (2008) 1.35
The role of AUF1 in regulated mRNA decay. Wiley Interdiscip Rev RNA (2011) 1.34
Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J Virol (2005) 1.32
Assembly of AUF1 with eIF4G-poly(A) binding protein complex suggests a translation function in AU-rich mRNA decay. RNA (2006) 1.22
Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol (2008) 1.20
Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology (2006) 1.17
Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol (2005) 1.16
A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J Virol (2005) 1.16
Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J Virol (2004) 1.16
Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches. Antivir Ther (2002) 1.07
Modulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1. Front Biosci (Landmark Ed) (2011) 1.06
Alternate exon insertion controls selective ubiquitination and degradation of different AUF1 protein isoforms. Nucleic Acids Res (2002) 1.06
Identification of a novel AU-rich-element-binding protein which is related to AUF1. Biochem J (2002) 1.04
Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat Rev Microbiol (2013) 1.04
HPV-16 RNA processing. Front Biosci (2008) 1.01
HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation. EMBO J (2012) 1.00
hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res (2010) 0.99
hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration. Cancer Res (2009) 0.97
Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci U S A (2010) 0.96
A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions. Cell Cycle (2009) 0.92
Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. Nucleic Acids Res (2011) 0.90
HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. Virology (2004) 0.89
Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome. J Virol (2010) 0.89
The HPV transcriptome in HPV16 positive cell lines. Mol Cell Probes (2011) 0.88
Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology (2007) 0.86
Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor. Oncogene (2006) 0.85
Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism. J Gen Virol (2011) 0.85
Molecular recognition of an RNA trafficking element by heterogeneous nuclear ribonucleoprotein A2. Biochemistry (2006) 0.85
Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3. J Biol Chem (2010) 0.84
Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region. Virus Genes (2007) 0.81
Development and validation of a novel reporter assay for human papillomavirus type 16 late gene expression. J Virol Methods (2012) 0.81
Regulation of splicing-associated SR proteins by HPV-16. Biochem Soc Trans (2006) 0.80
NRF IRES activity is mediated by RNA binding protein JKTBP1 and a 14-nt RNA element. RNA (2007) 0.80
The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci U S A (2003) 2.62
Treatment of skin papillomas with topical alpha-lactalbumin-oleic acid. N Engl J Med (2004) 2.38
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood (2012) 2.27
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood (2006) 2.15
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood (2013) 1.65
High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J Clin Oncol (2006) 1.57
The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group. Blood (2009) 1.53
CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol (2010) 1.51
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica (2009) 1.48
Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol (2007) 1.32
Multi-decadal changes in tundra environments and ecosystems: synthesis of the International Polar Year-Back to the Future project (IPY-BTF). Ambio (2011) 1.29
IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One (2012) 1.23
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. PLoS One (2013) 1.17
Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. J Hypertens (2004) 1.17
A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J Virol (2005) 1.16
Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J Virol (2004) 1.16
Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapy. Support Care Cancer (2003) 1.10
The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol (2005) 1.09
Functional activities and cellular localization of the ezrin, radixin, moesin (ERM) and RING zinc finger domains in MIR. FEBS Lett (2003) 1.09
CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy. Haematologica (2008) 1.05
HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects. Adv Cancer Res (2003) 1.05
Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat Rev Microbiol (2013) 1.04
Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region. J Biol Chem (2002) 1.04
Apoptosis-like death in bacteria induced by HAMLET, a human milk lipid-protein complex. PLoS One (2011) 1.03
Patients' age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group. Blood (2008) 1.02
Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Res (2004) 1.01
HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation. EMBO J (2012) 1.00
Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer. J Med Virol (2009) 0.99
Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J Gen Virol (2009) 0.99
Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Ann Hematol (2005) 0.99
A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J Virol (2005) 0.99
Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J Virol (2003) 0.98
Lipids as cofactors in protein folding: stereo-specific lipid-protein interactions are required to form HAMLET (human alpha-lactalbumin made lethal to tumor cells). Protein Sci (2003) 0.98
HAMLET (human alpha-lactalbumin made lethal to tumor cells) triggers autophagic tumor cell death. Int J Cancer (2009) 0.97
NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood (2006) 0.94
Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica (2007) 0.94
Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol (2014) 0.94
CNS aspergillosis: recognition, diagnosis and management. CNS Drugs (2007) 0.93
Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells. Proc Natl Acad Sci U S A (2013) 0.93
Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells). Adv Exp Med Biol (2008) 0.92
Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J Virol (2013) 0.92
Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clin Infect Dis (2004) 0.90
alpha-Lactalbumin, engineered to be nonnative and inactive, kills tumor cells when in complex with oleic acid: a new biological function resulting from partial unfolding. J Mol Biol (2009) 0.90
Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome. J Virol (2010) 0.89
HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. Virology (2004) 0.89
alpha-Lactalbumin species variation, HAMLET formation, and tumor cell death. Biochem Biophys Res Commun (2006) 0.89
Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm. Virus Res (2011) 0.89
Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia. Haematologica (2010) 0.89
Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res Hum Retroviruses (2004) 0.88
Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Br J Haematol (2003) 0.88
Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia. Haematologica (2009) 0.87
Alpha-lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human alpha-lactalbumin made lethal to tumor cells). Protein Sci (2003) 0.87
The presence of inhibitory RNA elements in the late 3'-untranslated region is a conserved property of human papillomaviruses. Virus Res (2007) 0.86
Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection. Proc Natl Acad Sci U S A (2013) 0.86
Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy. Pharmacotherapy (2013) 0.86
Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology (2007) 0.86
Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle. Virology (2009) 0.86
Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomas. Br J Haematol (2003) 0.85
Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism. J Gen Virol (2011) 0.85
Dendritic cells as inducers of antimicrobial immunity in vivo. APMIS (2003) 0.85
Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy. Mycoses (2011) 0.85
Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3. J Biol Chem (2010) 0.84
Hydrops lysosomalis generalisatus--an underestimated side effect of hydroxyethyl starch therapy? Eur J Haematol (2006) 0.84
Expression of interleukin 15 in primary adult acute lymphoblastic leukemia. Cancer (2010) 0.84
Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL). Hematol Oncol (2006) 0.84
Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant (2008) 0.83
Adenosine treatment attenuates cytokine interleukin-6 responses to endotoxin challenge in healthy volunteers. Shock (2003) 0.83
A digital heterodyne laser interferometer for studying cochlear mechanics. J Neurosci Methods (2009) 0.83
Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization. Ann Hematol (2013) 0.82
Adenovirus E4orf4 induces HPV-16 late L1 mRNA production. Virology (2008) 0.82
Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients. J Hematol Oncol (2014) 0.82
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse. Exp Hematol Oncol (2012) 0.81
No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms. Retrovirology (2007) 0.81
Development and validation of a novel reporter assay for human papillomavirus type 16 late gene expression. J Virol Methods (2012) 0.81
HAMLET kills tumor cells by apoptosis: structure, cellular mechanisms, and therapy. J Nutr (2005) 0.81
Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region. Virus Genes (2007) 0.81
An intron 9 containing splice variant of PAX2. J Transl Med (2009) 0.81
Endogenous filamentous fungal endophthalmitis--single-centre survey in patients with acute leukaemia or postallogeneic stem cell transplantation and review of the literature. Mycoses (2011) 0.81
Inefficient splicing of segment 7 and 8 mRNAs is an inherent property of influenza virus A/Brevig Mission/1918/1 (H1N1) that causes elevated expression of NS1 protein. Virology (2011) 0.80
HAMLET binding to α-actinin facilitates tumor cell detachment. PLoS One (2011) 0.80
Noise-induced alterations in cochlear mechanics, electromotility, and cochlear amplification. Pflugers Arch (2012) 0.80
DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection. Eur J Immunol (2014) 0.80
Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. Cancer Res (2007) 0.80
Compact oleic acid in HAMLET. FEBS Lett (2005) 0.79
Stability of HAMLET--a kinetically trapped alpha-lactalbumin oleic acid complex. Protein Sci (2005) 0.79
Molecular analysis of the t(2;8)/MYC-IGK translocation in high-grade lymphoma/leukemia by long-distance inverse PCR. Genes Chromosomes Cancer (2011) 0.79
Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma. Mol Oncol (2013) 0.79
Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes. PLoS One (2013) 0.79
Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group. Haematologica (2014) 0.78
Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome. Ann Hematol (2009) 0.78
Involvement of the MLL gene in adult T-lymphoblastic leukemia. Genes Chromosomes Cancer (2012) 0.77
External validity of the ARISTOTLE trial in real-life atrial fibrillation patients. Cardiovasc Ther (2014) 0.77
Intramedullary abscess in a patient with disseminated Scedosporium apiospermum infection. Br J Haematol (2003) 0.77